Bone metastases are at the center of advanced prostate cancer care, with over 90% of patients with metastatic prostate cancer expected to have bone involvement. 1 These metastatic ...
Zoledronic acid is a potent, new-generation bisphosphonate indicated for the treatment of documented bone metastasis in patients with solid tumors and bone lesions associated with multiple myeloma.
Androgen deprivation is the mainstay of advanced prostate cancer treatment. Despite initial ... of skeletal-related events (SREs) in bone metastatic CRPC (mCRPC). Denosumab compared with ...
Investigators conducted a retrospective review that spanned 10 years with the goals of describing the clinical characteristics of choroidal metastasis in this patient population and report treatment ...
A chest roentgenogram at that time showed changes suggesting tuberculosis, and he was admitted to another institution for treatment ... usually associated with bone metastases characterized ...
Enrollment is underway for a clinical trial that will evaluate whether smartwatch technology can allow for earlier detection of lymphedema. The HHS’ Interagency Coordinating Committee on the ...